Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 27846-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- C22orf25 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated C22orf25 antibody (Cat. #27846-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, Mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Intrinsic and extrinsic regulation of rhabdomyolysis susceptibility by Tango2.
HRG-9 homologues regulate haem trafficking from haem-enriched compartments.
The phenotype associated with variants in TANGO2 may be explained by a dual role of the protein in ER-to-Golgi transport and at the mitochondria.
Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect.
Kim ES, Casey JG, Tao BS, Mansur A, Mathiyalagan N, Wallace ED, Ehrmann BM, Gupta VA
Disease models & mechanisms 2023 Sep 1;16(9)
Disease models & mechanisms 2023 Sep 1;16(9)
HRG-9 homologues regulate haem trafficking from haem-enriched compartments.
Sun F, Zhao Z, Willoughby MM, Shen S, Zhou Y, Shao Y, Kang J, Chen Y, Chen M, Yuan X, Hamza I, Reddi AR, Chen C
Nature 2022 Oct;610(7933):768-774
Nature 2022 Oct;610(7933):768-774
The phenotype associated with variants in TANGO2 may be explained by a dual role of the protein in ER-to-Golgi transport and at the mitochondria.
Milev MP, Saint-Dic D, Zardoui K, Klopstock T, Law C, Distelmaier F, Sacher M
Journal of inherited metabolic disease 2021 Mar;44(2):426-437
Journal of inherited metabolic disease 2021 Mar;44(2):426-437
Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect.
Bérat CM, Montealegre S, Wiedemann A, Nuzum MLC, Blondel A, Debruge H, Cano A, Chabrol B, Hoebeke C, Polak M, Stoupa A, Feillet F, Torre S, Boddaert N, Bruel H, Barth M, Damaj L, Abi-Wardé MT, Afenjar A, Benoist JF, Madrange M, Caccavelli L, Renard P, Hubas A, Nusbaum P, Pontoizeau C, Gobin S, van Endert P, Ottolenghi C, Maltret A, de Lonlay P
Journal of inherited metabolic disease 2021 Mar;44(2):415-425
Journal of inherited metabolic disease 2021 Mar;44(2):415-425
No comments: Submit comment
No validations: Submit validation data